Elicit
Delaware corporation · 6 known investors
Elicit is an AI-powered research assistant that helps users discover, analyze, and synthesize scientific literature and research findings. The platform serves researchers, academics, and professionals in life sciences, healthcare, and related fields who need to conduct evidence-based analysis at scale.
Founders & leadership
AS

Andreas StuhlmüllerCo-founder
JB
Jungwon Byun
Investors · 6
Reported raises · per SEC filings
Form D private placements▶$11MraisedAug 2023 · 6 investors · Other TechnologyRule 506(b)
▶$11MraisedAug 2023 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Andreas StuhlmullerExecutive Officer, Director, Promoter
- Jungwon ByunExecutive Officer, Director
- Offering amount
- $11M
- Amount sold
- $11M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Elicit's $22M Series A - Deploying AI to radically increase good reasoning in the worldcreativerly.com · 2025
- Elicit - by Nikhil Basu Trivedi and Mike Smithnbt.substack.com · 2025
- Elicit Plant Raises $48M in Series B Fundingfinsmes.com · 2024
- Revolutionizing Research: AI Company Elicit Secures $9 Million in Seed Round Funding | SignalBasetrysignalbase.com · 2024